Do delirium and Alzheimer's dementia share specific pathogenetic mechanisms

Dementia and Geriatric Cognitive Disorders

Volumn 10, Issue 5, 1999, Pages 319-324

  Eikelenboom, Piet ^a,b   Hoogendijk, Witte J G ^a  

^a Department of Anatomy and Embryology   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Acute phase response; Alzheimer's dementia; Circadian rhythms; Delirium; Inflammation; Interleukins; Stress reaction

Indexed keywords

ALZHEIMER DISEASE; BRAIN METABOLISM; CHOLINERGIC SYSTEM; COMORBIDITY; CONFERENCE PAPER; DELIRIUM; HUMAN; INFLAMMATION; NORADRENERGIC SYSTEM; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; SLEEP DISORDER; STRESS;

AGED; ALZHEIMER DISEASE; BRAIN; DELIRIUM; HUMANS; INFLAMMATION; SLEEP DISORDERS; STRESS;

EID: 0032796101     PISSN: 14208008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000017162     Document Type: Conference Paper

References (44)

1. Lefkoff S, Cleary P, Liptzin B, Evans DA: Epidemiology of delirium: An overview of research issues and findings. Int Psychogeriatr 1991;3:149-167.
2. Elie M, Cole MG, Primeau FJ, Bellavance F: Delirium risk factors in elderly hospitalized patients. J Gen Intern Med 1998;13:204-212.
3. Lerner AJ, Hedera P, Koss E, Stuckey J, Friedland RP: Delirium in Alzheimer's disease. Alzheimer Dis Assoc Disord 1997;11:16-20.
4. Robertsson B, Blennow K, Gottfries CG, Wallin A: Delirium in dementia. Int J Geriatr Psychiatry 1998;13:49-56.
5. Murray AM, Levkoff SE, Wetle TT, Becket L, Clearly PD, Scor JD, Lipsitz LA, Rowe JW, Evans DE: Acute delirium and functional decline in the hospitalized elderly patient. J Gerontol 1993;48:181-186.
6. Lipowski ZJ: Delirium: Acute Confusional States. Oxford, Oxford University Press, 1990.
7. Lindesay J, MacDonald A, Starke I: Delirium in the Elderly. Oxford, Oxford University Press, 1990.
8. Engel GL, Romano J: Delirium, a syndrome of cerebral insufficiency. J Chronic Dis 1959;9: 260-277.
9. Gibson GE, Blass JP, Huang FM, Freeman GB: The cellular basis of delirium and its relevance to age-related disorders including Alzheimer's disease. Int Psychogeriatr 1991;3: 373-395.
10. Itil T, Fink M: Anticholinergic drug-induced delirium; experimental modification, quantitative EEG and behavioral correlations. J Nerv Ment Dis 1966;143:492-507.
11. Bonhoeffer K: Die Psychosen; in Handbuch der Psychiatrie, spezieller Teil III-1. Leipzig, Franz Deutsche, 1912.
12. Blalock JE: The syntaxis of immune-neuroendocrine interactions. Immunol Today 1994;15: 504-511.
13. Stefane GB, Bilfinger TV, Fricchione GL: The immune-neuro-link and the macrophage: Post-cardiotomy delirium, HIV-associated dementia and psychiatry. Prog Neurobiol 1994;42: 475-488.
14. McClain CJ, Cohen D, Ott L, Dinarello CA, Young B: Ventricular fluid interleukin-1 activity in patients with head injury. J Lab Clin Med 1987;110:48-54.
15. McGeer PL, McGeer EG: Inflammatory cytokines in the CNS. CNS Drugs 1997;7:214-228.
16. Rada P, Mark GP, Vitek MP, Mangano RM, Blum AJ, Beer B, Hoebel BG: Interleukin-1β decreases acetylcholine measured by microdialysis in the hippocampus of freely moving rats. Brain Res 1991;550:287-290.
17. Dunn AJ: Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism parallelling the increased plasma corticosterone. Life Sci 1988;43:429-435.
18. Krai VA: Stress and mental disorders of the senium. Med Serv J Can 1962;18:363-370.
19. Hoyer S: Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis. J Neural Transm 1998;105:415-422.
20. Müch G, Schinzel R, Loske C, Wong A, Durany N, Li JJ, Vlassara H, Smith MA, Perry G, Riederer P: Alzheimer's disease-synergistic effects of glucose deficit, oxidative stress and advanced glycolation endproducts. J Neural Transm 1998;105:439-461.
21. Frölich L, Blum-Degen D, Bernstein H-G, Engelsberger S, Humrich J, Laufer S, Muschner D, Thalmeier A, Türk A, Hoyer S, Zöchling R, Boisel KW, Jellinger K, Riederer P: Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease. J Neural Transm 1998; 105:423-438.
22. Gottfries CG: Neurochemical aspects of dementia disorders. Dementia 1990;1:56-64.
23. Hoogendijk WJG, Pool ChW, Troost D, Van Zwieten EJ, Swaab DF: Image analyser-assisted morphometry of the locus coeruleus in Alzheimer's disease, Parkinson's disease and amyotrophic lateral slcerosis. Brain 1995;118: 131-143.
24. Hoogendijk WJG, Feenstra MGP, Botterblom MHA, Gilhuis J, Sommer IEC, Kamphorst W, Eikelenboom P, Swaab DF: Increased activity of surviving locus coeruleus neurons in Alzheimer's disease. Ann Neurol 1999;45:82-91.
25. Selkoe DJ: Normal and abnormal biology of β-amyloid precursor protein. Annu Rev Neurosci 1994;17:489-517.
26. Eikelenboom P, Stam FC: Immunoglobulins and complement factors in senile plaques. Acta Neuropathol 1982;57:239-242.
27. Rozemuller JM, Eikelenboom P, Stam FC, Beyreuther K, Masters CL: A4 protein in Alzheimer's disease: Primary and secondary cellular events in extracellular amyloid deposition. J Neuropathol Exp Neurol 1989;48:674-691.
28. Eikelenboom P, Zhan SS, Van Gool WA, Eikelenboom P: Inflammatory mechanisms in Alzheimer's disease. Trends Pharmacol Sci 1994; 15:147-150.
29. Van Gool J, van Vugt H, Helle M, Aarden LA: The relation among stress, adrenalin, interleukin 6 and acute phase proteins in the rat. Clin Immunol Immunopathol 1990;57:200-210.
30. McGeer PL, Schulzer M, McGeer EG: Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiological cases. Neurology 1996;47:425-432.
31. Raskind MA, Peskind E, Rivard MF, Veith R, Barnes R: The dexamethasone suppression test and Cortisol circadiane rhythm in primary degenerative dementia. Am J Psychiatry 1982; 139:1468-1471.
32. Raadsheer FC, van Heerikhuize JJ, Lucassen PJ, Hoogendijk WJ, Tilders FJ, Swaab DF: Corticotropin-releasing hormone mRNA levels in the paraventricular nucleus of patients with Alzheimer's disease and depression. Am J Psychiatry 1995;152:1372-1376.
33. Sanford JRA: Tolerance of debility in elderly dependents by supporters at home: Its significance for hospital practice. Br Med J 1975;iii: 471-473.
34. Swaab DF, Fliers E, Partiman TS: The suprachiasmatic nucleus in the human brain in relation to sex, age and senile dementia. Brain Res 1985;342:37-44.
35. Witting W, Kwa IH, Eikelenboom P, Mirmiran M, Swaab DF: Alterations in the circadian restactivity rhythm in aging and Alzheimer's disease. Biol Psychiatry 1990;27:563-572.
36. Salehi A, Lucassen PJ, Pool CW, Ravid R, Gonatas NK, Swaab DF: Decreased neuronal activity in the nucleus basalis of Meynert in Alzheimer's disease as suggested by the size of the Golgi apparatus. Neuroscience 1994;59: 871-880.
37. Koponen H, Stenbäck U, Mattila E, Soininen H, Reinikainen K, Riekkinen PJ: Delirium among elderly persons admitted to a psychiatric hospital: Clinical course during the acute stage and one-year follow-up. Acta Psychiatr Scand 1989;79:579-585.
38. Van Dam A-M, de Vries HE, Kuiper J, Zijlstra FJ, de Boer AG, Tilders FJH, Berkenbosch F: Interleukin-1 receptors on rat brain endothelial cells; a role in neuroimmune interactions? FASEB J 1996;10:351-356.
39. Hofman A, Ott A, Breteler MMB, Bots ML, Slooter AJC, van Harskamp F, van Duyn CM, van Broeckhoven C, Grobbee DE: Artherosclerosis, apoliprotein E, and the prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet 1997;349:151-154.
40. Wallin A, Blennow K, Fredman P, Gottfries CG, Karlsson I, Svennerholm L: Blood-brain barrier function in vascular dementia. Acta Neurol Scand 1990;81:318-322.
41. Blennow K, Wallin A, Fredman I, Karlsson I, Gottfries CG, Svennerholm L: Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors. Acta Neurol Scand 1990;81:323-326.
42. Blennow K, Wallin A, Gottfries CG: Confusional symptomatology distinguishes early-and late-onset Alzheimer's disease. Aging 1990;2: 395-401.
43. Kushner I: The acute phase response: An overview. Methods Enzymol 1988; 163:373-383.
44. Eikelenboom P, Rozemuller JM, van Muiswinkel FL: Inflammation and Alzheimer's disease: Relationships between pathogenic mechanisms and clinical expression. Exp Neurol 1998;154: 89-98.